Free Trial
NASDAQ:INGN

Inogen (INGN) Stock Price, News & Analysis

Inogen logo
$9.20 -0.26 (-2.75%)
(As of 03:03 PM ET)

About Inogen Stock (NASDAQ:INGN)

Key Stats

Today's Range
$9.20
$9.49
50-Day Range
$8.69
$11.33
52-Week Range
$4.93
$13.33
Volume
102,371 shs
Average Volume
330,425 shs
Market Capitalization
$219.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Hold

Company Overview

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
61st Percentile Overall Score

INGN MarketRank™: 

Inogen scored higher than 61% of companies evaluated by MarketBeat, and ranked 433rd out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inogen has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Inogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Inogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Inogen are expected to grow in the coming year, from ($1.73) to ($1.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inogen is -4.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inogen is -4.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Inogen has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Inogen's valuation and earnings.
  • Percentage of Shares Shorted

    3.47% of the outstanding shares of Inogen have been sold short.
  • Short Interest Ratio / Days to Cover

    Inogen has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Inogen has recently decreased by 11.40%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Inogen does not currently pay a dividend.

  • Dividend Growth

    Inogen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.47% of the outstanding shares of Inogen have been sold short.
  • Short Interest Ratio / Days to Cover

    Inogen has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Inogen has recently decreased by 11.40%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Inogen has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Inogen this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for INGN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inogen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.99% of the stock of Inogen is held by insiders.

  • Percentage Held by Institutions

    89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Inogen's insider trading history.
Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Stock News Headlines

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
Inogen, Inc. Reports Third Quarter 2024 Financial Results
Needham Keeps Their Hold Rating on Inogen (INGN)
Inogen, Inc. (INGN): A Bear Case Theory
See More Headlines

INGN Stock Analysis - Frequently Asked Questions

Inogen's stock was trading at $5.49 at the beginning of the year. Since then, INGN shares have increased by 67.6% and is now trading at $9.20.
View the best growth stocks for 2024 here
.

Inogen, Inc. (NASDAQ:INGN) released its quarterly earnings results on Tuesday, August, 6th. The medical technology company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.55) by $0.31. The business's revenue for the quarter was up 6.1% compared to the same quarter last year.

Inogen's top institutional shareholders include Brown Capital Management LLC (6.57%), Fred Alger Management LLC (2.99%), Geode Capital Management LLC (2.33%) and State Street Corp (2.15%). Insiders that own company stock include Jason Somer and Ray Benjamin M Anderson.
View institutional ownership trends
.

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inogen investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/06/2024
Today
11/21/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/25/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:INGN
Fax
N/A
Employees
834
Year Founded
2001

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
-23.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-102,450,000.00
Pretax Margin
-16.13%

Debt

Sales & Book Value

Annual Sales
$315.66 million
Book Value
$7.78 per share

Miscellaneous

Free Float
23,582,000
Market Cap
$219.14 million
Optionable
Optionable
Beta
1.04

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:INGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners